Climate Change Data

Myomo, Inc.

Climate Impact & Sustainability Data (2019)

Reporting Period: 2019

Environmental Metrics

Social Achievements

  • Launched a Department of Patient Advocacy to assist patients and O&P Centers of Excellence in obtaining insurance coverage for MyoPro orthosis.

Climate Goals & Targets

Short-term Goals:
  • Reach cash-flow breakeven on a quarterly basis by the fourth quarter of 2021 (subject to COVID-19 impact).

Environmental Challenges

  • Direct Billing revenue cycle times are longer (90-180 days), impacting revenue recognition.
  • Uncertainty regarding CMS coverage policy and reimbursement amounts for MyoPro products.
  • Dependence on a single third-party manufacturer (Cogmedix) and limited suppliers for components.
  • Dependence on a related third-party (GRE) for custom fabrication of MyoPro.
  • Limited operating history makes it difficult to evaluate future business prospects.
  • History of operating losses and negative cash flows.
  • Potential for significant fluctuations in quarterly and annual results.
  • Uncertainty in obtaining third-party payer reimbursement for products.
  • Intense competition in the medical robotics industry.
  • Risks associated with international expansion.
  • Dependence on key personnel.
  • Risks related to acquisitions (if pursued).
  • Extensive governmental regulations.
  • Potential for cyber-attacks or security breaches.
  • Risks related to the Affordable Care Act (ACA) or its replacement.
  • Dependence on licensed patents.
  • Risks related to intellectual property protection.
  • Potential for significant dilution upon issuance of common stock.
  • Potential delisting from NYSE American.
  • Stock price volatility.
  • Increased costs as a public company.
Mitigation Strategies
  • Established a Customer Experience team to speed up the patient inquiry to device delivery and payment process.
  • Working with CMS on reimbursement guidelines.
  • Seeking additional sources for manufacturing and custom fabrication.
  • Seeking other fabrication partners for MyoPro.
  • Completed a public equity offering to secure funding.
  • Implementing cost reduction measures.
  • Expanding sales and marketing efforts.
  • Developing new products (pediatric MyoPro).
  • Conducting clinical research studies.
  • Implementing security measures to mitigate cyber-attacks.
  • Monitoring industry trends relative to the ACA.
  • Protecting intellectual property through patents and trademarks.
  • Maintaining compliance with governmental regulations.

Supply Chain Management

Climate-Related Risks & Opportunities